Gene environment interaction studies in depression and suicidal behavior: An update

Neuroscience and Biobehavioral Reviews

Volumn 37, Issue 10, 2013, Pages 2375-2397

  Mandelli, Laura ^a   Serretti, Alessandro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Environment; Gene environment interaction; Genetics; Major depression; Stressful life events; Suicide

Indexed keywords

4 AMINOBUTYRIC ACID; APOLIPOPROTEIN E; BRAIN DERIVED NEUROTROPHIC FACTOR; CELL RECEPTOR; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE; DOPAMINE; ENDOCANNABINOID; FK506 BINDING PROTEIN 5; GLUTAMIC ACID; GLUTATHIONE PEROXIDASE; GLYCOGEN SYNTHASE; IMMUNOPHILIN; NEUROPEPTIDE Y; NORADRENALIN; NUCLEAR RECEPTOR NR3C1; ORNITHINE DECARBOXYLASE; OXYTOCIN; RGS2 PROTEIN; SEROTONIN; UNCLASSIFIED DRUG;

ENVIRONMENTAL FACTOR; ENVIRONMENTAL STRESS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LIFE STRESS; MAJOR DEPRESSION; MONOAMINERGIC SYSTEM; NEUROMODULATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SUICIDAL BEHAVIOR; SYSTEMATIC REVIEW;

ABCG1; ACE; ANGIOTENSIN-CONVERTING ENZYME; APOE; APOLIPROTEIN E; ARGIVANINE VASOPRESSIN RECEPTOR 1B; ATP-BINDING CASSETTE SUBFAMILY G MEMBER 1; AVPR1B; BDNF; BRAIN-DERIVED NEUROTROPHIC FACTOR; CANNABINOID RECEPTOR 1; CATECHOL-O-METHYLTRANSFERASE A; CNR1; COMT; CORTICOTROPHIN-RELEASING HORMONE; CORTICOTROPHIN-RELEASING HORMONE BINDING PROTEIN; CORTICOTROPHIN-RELEASING HORMONE RECEPTOR 1; CORTICOTROPHIN-RELEASING HORMONE RECEPTOR 2; CRH; CRHBP; CRHR1; CRHR2; DBH; DOPAMINE BETA-HYDROXYLASE; DOPAMINE RECEPTOR D1; DOPAMINE RECEPTOR D2; DOPAMINE RECEPTOR D3; DOPAMINE RECEPTOR D4; DRD1; DRD2; DRD3; DRD4; DRD5; ENVIRONMENT; FK506-BINDING PROTEIN 5; FKBP5; FMR1; FRAGILE-X MENTAL RETARDATION PROTEIN; GABRA1; GABRA2; GABRA5; GABRG1; GABRG2; GAD1G; GAMMA-AMINOBUTYRIC ACID RECEPTOR ALPHA1; GAMMA-AMINOBUTYRIC ACID RECEPTOR ALPHA2; GAMMA-AMINOBUTYRIC ACID RECEPTOR ALPHA5; GAMMA-AMINOBUTYRIC ACID RECEPTOR GAMMA1; GAMMA-AMINOBUTYRIC ACID RECEPTOR GAMMA2; GENE-ENVIRONMENT INTERACTION; GENETICS; GENE×ENVIRONMENT INTERACTION; GLULG; GLUTAMATE RECEPTOR IONOTROPIC 2C (GLUTAMATE RECEPTOR 2C); GLUTAMATE RECEPTOR IONOTROPIC 2D (GLUTAMATE RECEPTOR 2D); GLUTAMATE RECEPTOR IONOTROPIC 3A (GLUTAMATE RECEPTOR 3A); GLUTAMATE RECEPTOR IONOTROPIC 3B (GLUTAMATE RECEPTOR 3B); GLUTAMATE RECEPTOR METABOTROPIC 7; GLUTATHIONE PEROXIDASE; GLYCOGEN-SYNTHASE 3BETA; GPX1; GRIA1G; GRIN2AG; GRIN2BG; GRIN2C; GRIN2D; GRIN3A; GRIN3B; GRM7; GSK3B; G×E; HTR1A; HTR1B; HTR2A; HTR2C; HTR3A; IL10; IL18; INTERLEUKIN 10; INTERLEUKIN 18; LUTAMATE DECARBOXYLASE 1; LUTAMATE RECEPTOR IONOTROPIC 2A (GLUTAMATE RECEPTOR 2A); LUTAMATE RECEPTOR IONOTROPIC 2B (GLUTAMATE RECEPTOR 2B); LUTAMATE RECEPTOR IONOTROPIC AMPA 1 (GLUTAMATE RECEPTOR 1); LUTAMATE-AMMONIA LIGASE (GLUTAMINE SYNTHASE); MAJOR DEPRESSION; MAOA; MD; MONOAMINE-OXIDASE A; NEURONAL TRYPTOPHAN HYDROXYLASE; NEUROPEPTIDE Y; NEUROTROPHIC TYROSINE KINASE RECEPTOR 2; NPY; NR3C1; NTRK2; NUCLEAR RECEPTOR SUB FAMILY 3 GROUP C MEMBER 1 (GLUCOCORTICOID RECEPTOR); ODC1; ORNITHINE DECARBOXYLASE 1; OXTR; OXYTOCIN RECEPTOR; REGULATOR OF G-PROTEIN SIGNALING 2; RGS2; SB; SEROTONIN RECEPTOR 1A; SEROTONIN RECEPTOR 2A; SEROTONIN RECEPTOR 2B; SEROTONIN RECEPTOR 2C; SEROTONIN RECEPTOR 3A; SLC6A2; SLC6A3; SLC6A4; SLES; SOLUTE CARRIER 6 A2 (NORADRENALIN TRANSPORTER; SOLUTE CARRIER 6 A3 (DOPAMINE TRANSPORTER); SOLUTE CARRIERS 6A (SEROTONIN TRANSPORTER); STRESSFUL LIFE EVENTS; SUICIDAL BEHAVIOR; SUICIDE; TNF; TPH1; TPH2; TRYPTOPHAN HYDROXYLASE; TUMOR NECROSIS FACTOR;

DEPRESSIVE DISORDER, MAJOR; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIFE CHANGE EVENTS; SUICIDE;

EID: 84890245268     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2013.07.011     Document Type: Review

References (192)

1. Agrawal A., Nelson E.C., Littlefield A.K., Bucholz K.K., Degenhardt L., Henders A.K., Madden P.A., Martin N.G., Montgomery G.W., Pergadia M.L., Sher K.J., Heath A.C., Lynskey M.T. Cannabinoid receptor genotype moderation of the effects of childhood physical abuse on anhedonia and depression. Archives of General Psychiatry 2012, 69:732-740.
2. Aguilera M., Arias B., Wichers M., Barrantes-Vidal N., Moya J., Villa H., van Os J., Ibanez M.I., Ruiperez M.A., Ortet G., Fananas L. Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions on depressive symptoms in a general population. Psychological Medicine 2009, 39:1425-1432.
3. Amstadter A.B., Koenen K.C., Ruggiero K.J., Acierno R., Galea S., Kilpatrick D.G., Gelernter J. Variation in RGS2 is associated with suicidal ideation in an epidemiological study of adults exposed to the 2004 Florida hurricanes. Archives of Suicide Research 2009, 13:349-357.
4. Angles M.R., Ocana D.B., Medellin B.C., Tovilla-Zarate C. No association between the HTR1A gene and suicidal behavior: a meta-analysis. Revista Brasileira de Psiquiatria 2012, 34:38-42.
5. Anguelova M., Benkelfat C., Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior. Molecular Psychiatry 2003, 8:646-653.
6. Appel K., Schwahn C., Mahler J., Schulz A., Spitzer C., Fenske K., Stender J., Barnow S., John U., Teumer A., Biffar R., Nauck M., Volzke H., Freyberger H.J., Grabe H.J. Moderation of adult depression by a polymorphism in the FKBP5 gene and childhood physical abuse in the general population. Neuropsychopharmacology 2011, 36:1982-1991.
7. Bao A.M., Meynen G., Swaab D.F. The stress system in depression and neurodegeneration: Focus on the human hypothalamus. Brain Research Reviews 2008, 57:531-553.
8. Barrero F.J., Ampuero I., Morales B., Vives F., de Dios Luna Del Castillo J., Hoenicka J., Garcia Yebenes J. Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1). Pharmacogenomics Journal 2005, 5:135-141.
9. Baune B.T., Thome J. Translational research approach to biological and modifiable risk factors of psychosis and affective disorders. World Journal of Biological Psychiatry 2011, 12(Suppl 1):28-34.
10. Bellivier F., Chaste P., Malafosse A. Association between the TPH gene A218C polymorphism and suicidal behavior: a meta-analysis. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2004, 124B:87-91.
11. Ben-Efraim Y.J., Wasserman D., Wasserman J., Sokolowski M. Gene-environment interactions between CRHR1 variants and physical assault in suicide attempts. Genes, Brain, and Behavior 2011, 10:663-672.
12. Ben-Efraim Y.J., Wasserman D., Wasserman J., Sokolowski M. Family-based study of HTR2A in suicide attempts: observed gene, gene×environment and parent-of-origin associations. Molecular Psychiatry 2012, 18:758-766.
13. Ben-Efraim Y.J., Wasserman D., Wasserman J., Sokolowski M. Family-based study of AVPR1B association and interaction with stressful life events on depression and anxiety in suicide attempts. Neuropsychopharmacology 2013, 38:1504-1511.
14. Bertelsen A., Harvald B., Hauge M. A Danish twin study of manic-depressive disorders. British Journal of Psychiatry 1977, 130:330-351.
15. Bet P.M., Penninx B.W., Bochdanovits Z., Uitterlinden A.G., Beekman A.T., van Schoor N.M., Deeg D.J., Hoogendijk W.J. Glucocorticoid receptor gene polymorphisms and childhood adversity are associated with depression: New evidence for a gene-environment interaction. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2009, 150B:660-669.
16. Bhang S., Ahn J.H., Choi S.W. Brain-derived neurotrophic factor and serotonin transporter gene-linked promoter region genes alter serum levels of brain-derived neurotrophic factor in humans. Journal of Affective Disorders 2011, 128:299-304.
17. Binder E.B., Salyakina D., Lichtner P., Wochnik G.M., Ising M., Putz B., Papiol S., Seaman S., Lucae S., Kohli M.A., Nickel T., Kunzel H.E., Fuchs B., Majer M., Pfennig A., Kern N., Brunner J., Modell S., Baghai T., Deiml T., Zill P., Bondy B., Rupprecht R., Messer T., Kohnlein O., Dabitz H., Bruckl T., Muller N., Pfister H., Lieb R., Mueller J.C., Lohmussaar E., Strom T.M., Bettecken T., Meitinger T., Uhr M., Rein T., Holsboer F., Muller-Myhsok B. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nature Genetics 2004, 36:1319-1325.
18. Borges G., Nock M.K., Haro Abad J.M., Hwang I., Sampson N.A., Alonso J., Andrade L.H., Angermeyer M.C., Beautrais A., Bromet E., Bruffaerts R., de Girolamo G., Florescu S., Gureje O., Hu C., Karam E.G., Kovess-Masfety V., Lee S., Levinson D., Medina-Mora M.E., Ormel J., Posada-Villa J., Sagar R., Tomov T., Uda H., Williams D.R., Kessler R.C. Twelve-month prevalence of and risk factors for suicide attempts in the World Health Organization World Mental Health Surveys. Journal of Clinical Psychiatry 2010, 71:1617-1628.
19. Bradley R.G., Binder E.B., Epstein M.P., Tang Y., Nair H.P., Liu W., Gillespie C.F., Berg T., Evces M., Newport D.J., Stowe Z.N., Heim C.M., Nemeroff C.B., Schwartz A., Cubells J.F., Ressler K.J. Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Archives of General Psychiatry 2008, 65:190-200.
20. Brandys M.K., Kas M.J., van Elburg A.A., Ophoff R., Slof-Op't Landt M.C., Middeldorp C.M., Boomsma D.I., van Furth E.F., Slagboom P.E., Adan R.A. The Val66Met polymorphism of the BDNF gene in anorexia nervosa: new data and a meta-analysis. World Journal of Biological Psychiatry 2013, in press.
21. Brent D.A., Mann J.J. Familial pathways to suicidal behavior - understanding and preventing suicide among adolescents. New England Journal of Medicine 2006, 355:2719-2721.
22. Brezo J., Bureau A., Merette C., Jomphe V., Barker E.D., Vitaro F., Hebert M., Carbonneau R., Tremblay R.E., Turecki G. Differences and similarities in the serotonergic diathesis for suicide attempts and mood disorders: a 22-year longitudinal gene-environment study. Molecular Psychiatry 2010, 15:831-843.
23. Brock J.F. Nature, nurture, and stress in health and disease. Lancet 1972, 1:701-704.
24. Bufalino C., Hepgul N., Aguglia E., Pariante C.M. The role of immune genes in the association between depression and inflammation: A review of recent clinical studies. Brain, Behavior, and Immunity 2012, 31:31-47.
25. Bukh J.D., Bock C., Vinberg M., Werge T., Gether U., Vedel Kessing L. Interaction between genetic polymorphisms and stressful life events in first episode depression. Journal of Affective Disorders 2009, 119:107-115.
26. Calati R., De Ronchi D., Bellini M., Serretti A. The 5-HTTLPR polymorphism and eating disorders: a meta-analysis. The International Journal of Eating Disorders 2011, 44:191-199.
27. Calati R., Porcelli S., Giegling I., Hartmann A.M., Moller H.J., De Ronchi D., Serretti A., Rujescu D. Catechol-o-methyltransferase gene modulation on suicidal behavior and personality traits: review, meta-analysis and association study. Journal of Psychiatric Research 2011, 45:309-321.
28. Carter C.J. Multiple genes and factors associated with bipolar disorder converge on growth factor and stress activated kinase pathways controlling translation initiation: implications for oligodendrocyte viability. Neurochemistry International 2007, 50:461-490.
29. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science (New York, NY) 2003, 301:386-389.
30. Castren E., Rantamaki T. Role of brain-derived neurotrophic factor in the aetiology of depression: implications for pharmacological treatment. CNS Drugs 2010, 24:1-7.
31. Chen D., Liu F., Yang C., Liang X., Shang Q., He W., Wang Z. Association between the TPH1 A218C polymorphism and risk of mood disorders and alcohol dependence: evidence from the current studies. Journal of Affective Disorders 2012, 138:27-33.
32. Chipman P., Jorm A.F., Tan X.Y., Esteal S. No association between the serotonin-1A receptor gene single nucleotide polymorphism rs6295C/G and symptoms of anxiety or depression, and no interaction between the polymorphism and environmental stressors of childhood anxiety or recent stressful life events on anxiety or depression. Psychiactric genetics 2010, 20:8-13.
33. Choi M.J., Lee H.J., Ham B.J., Cha J.H., Ryu S.H., Lee M.S. Association between major depressive disorder and the -1438A/G polymorphism of the serotonin 2A receptor gene. Neuropsychobiology 2004, 49:38-41.
34. Chou K.L. Moderating effect of apolipoprotein genotype on loneliness leading to depressive symptoms in Chinese older adults. American Journal of Geriatric Psychiatry 2010, 18:313-322.
35. Cicchetti D., Rogosch F.A., Sturge-Apple M.L. Interactions of child maltreatment and serotonin transporter and monoamine oxidase A polymorphisms: depressive symptomatology among adolescents from low socioeconomic status backgrounds. Development and Psychopathology 2007, 19:1161-1180.
36. Claes S.J. CRH, stress, and major depression: a psychobiological interplay. Vitamins and Hormones 2004, 69:117-150.
37. Clarke H., Flint J., Attwood A.S., Munafo M.R. Association of the 5-HTTLPR genotype and unipolar depression: a meta-analysis. Psychological Medicine 2010, 40:1767-1778.
38. Cohen H.J., Brown M.R., Hamilton D., Lyons-Patterson J., Avissar N., Liegey P. Glutathione peroxidase and selenium deficiency in patients receiving home parenteral nutrition: time course for development of deficiency and repletion of enzyme activity in plasma and blood cells. American Journal of Clinical Nutrition 1989, 49:132-139.
39. Comasco E., Sylven S.M., Papadopoulos F.C., Sundstrom-Poromaa I., Oreland L., Skalkidou A. Postpartum depression symptoms: a case-control study on monoaminergic functional polymorphisms and environmental stressors. Psychiatric Genetics 2011, 21:19-28.
40. Conway C.C., Hammen C., Brennan P.A., Lind P.A., Najman J.M. Interaction of chronic stress with serotonin transporter and catechol-O-methyltransferase polymorphisms in predicting youth depression. Depression and Anxiety 2010, 27:737-745.
41. Cooper B. Nature, nurture and mental disorder: old concepts in the new millennium. British Journal of Psychiatry 2001, 40:s91-s101.
42. Coventry W.L., James M.R., Eaves L.J., Gordon S.D., Gillespie N.A., Ryan L., Heath A.C., Montgomery G.W., Martin N.G., Wray N.R. Do 5HTTLPR and stress interact in risk for depression and suicidality? Item response analyses of a large sample. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2010, 153B:757-765.
43. Cui H., Nishiguchi N., Ivleva E., Yanagi M., Fukutake M., Nushida H., Ueno Y., Kitamura N., Maeda K., Shirakawa O. Association of RGS2 gene polymorphisms with suicide and increased RGS2 immunoreactivity in the postmortem brain of suicide victims. Neuropsychopharmacology 2008, 33:1537-1544.
44. Deltheil T., Guiard B.P., Cerdan J., David D.J., Tanaka K.F., Reperant C., Guilloux J.P., Coudore F., Hen R., Gardier A.M. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Neuropharmacology 2008, 55:1006-1014.
45. Dong C., Wong M.L., Licinio J. Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans. Molecular Psychiatry 2009, 14:1105-1118.
46. Dressler W.W., Balieiro M.C., Ribeiro R.P., Dos Santos J.E. Cultural consonance, a 5HT2A receptor polymorphism, and depressive symptoms: a longitudinal study of gene×culture interaction in urban Brazil. American Journal of Human Biology 2009, 21:91-97.
47. Du L., Bakish D., Lapierre Y.D., Ravindran A.V., Hrdina P.D. Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. American Journal of Medical Genetics 2000, 96:56-60.
48. El Mansari M., Guiard B.P., Chernoloz O., Ghanbari R., Katz N., Blier P. Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder. CNS Neuroscience & Therapeutics 2010, 16:e1-e17.
49. Elder B.L., Mosack V. Genetics of depression: an overview of the current science. Issues in Mental Health Nursing 2011, 32:192-202.
50. Eley T.C., Sugden K., Corsico A., Gregory A.M., Sham P., McGuffin P., Plomin R., Craig I.W. Gene-environment interaction analysis of serotonin system markers with adolescent depression. Molecular Psychiatry 2004, 9:908-915.
51. Enoch M.A., Goldman D., Barnett R., Sher L., Mazzanti C.M., Rosenthal N.E. Association between seasonal affective disorder and the 5-HT2A promoter polymorphism, -1438G/A. Molecular Psychiatry 1999, 4:89-92.
52. Esteban S., Garcia-Sevilla J.A. Effects induced by cannabinoids on monoaminergic systems in the brain and their implications for psychiatric disorders. Progress in Neuro-psychopharmacology & Biological Psychiatry 2012, 38:78-87.
53. Fan J., Sklar P. Genetics of bipolar disorder: focus on BDNF Val66Met polymorphism. Novartis Foundation Symposium 2008, 289(60-72):87-93. (discussion 72-63).
54. Fan M., Liu B., Jiang T., Jiang X., Zhao H., Zhang J. Meta-analysis of the association between the monoamine oxidase - a gene and mood disorders. Psychiatric Genetics 2010, 20:1-7.
55. Farmer A., Harris T., Redman K., Sadler S., Mahmood A., McGuffin P. Cardiff depression study. A sib-pair study of life events and familiality in major depression. British Journal of Psychiatry 2000, 176:150-155.
56. Fatemi S.H., Folsom T.D. The role of fragile X mental retardation protein in major mental disorders. Neuropharmacology 2011, 60:1221-1226.
57. Frustaci A., Pozzi G., Gianfagna F., Manzoli L., Boccia S. Meta-analysis of the brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in anxiety disorders and anxiety-related personality traits. Neuropsychobiology 2008, 58:163-170.
58. Fudalej S., Ilgen M., Fudalej M., Wojnar M., Matsumoto H., Barry K.L., Ploski R., Blow F.C. Clinical and genetic risk factors for suicide under the influence of alcohol in a Polish sample. Alcohol and Alcoholism (Oxford Oxfordshire) 2009, 44:437-442.
59. Fukumoto N., Fujii T., Combarros O., Kamboh M.I., Tsai S.J., Matsushita S., Nacmias B., Comings D.E., Arboleda H., Ingelsson M., Hyman B.T., Akatsu H., Grupe A., Nishimura A.L., Zatz M., Mattila K.M., Rinne J., Goto Y., Asada T., Nakamura S., Kunugi H. Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer's disease: new data and meta-analysis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2010, 153B:235-242.
60. Furlong R.A., Ho L., Walsh C., Rubinsztein J.S., Jain S., Paykel E.S., Easton D.F., Rubinsztein D.C. Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. American Journal of Medical Genetics 1998, 81:58-63.
61. Furlong R.A., Rubinsztein J.S., Ho L., Walsh C., Coleman T.A., Muir W.J., Paykel E.S., Blackwood D.H., Rubinsztein D.C. Analysis and metaanalysis of two polymorphisms within the tyrosine hydroxylase gene in bipolar and unipolar affective disorders. American Journal of Medical Genetics 1999, 88:88-94.
62. Gao J., Pan Z., Jiao Z., Li F., Zhao G., Wei Q., Pan F., Evangelou E. TPH2 gene polymorphisms and major depression - a meta-analysis. PLoS One 2012, 7:e36721.
63. Gatt J.M., Williams L.M., Schofield P.R., Dobson-Stone C., Paul R.H., Grieve S.M., Clark C.R., Gordon E., Nemeroff C.B. Impact of the HTR3A gene with early life trauma on emotional brain networks and depressed mood. Depression and Anxiety 2010, 27:752-759.
64. Gelenberg A.J. The prevalence and impact of depression. Journal of Clinical Psychiatry 2010, 71:e06.
65. Gibb B.E., McGeary J.E., Beevers C.G., Miller I.W. Serotonin transporter (5-HTTLPR) genotype, childhood abuse, and suicide attempts in adult psychiatric inpatients. Suicide & Life-threatening Behavior 2006, 36:687-693.
66. Gizatullin R., Zaboli G., Jönsson E.G., Asberg M., Leopardi R. The tryptophan hydroxylase (TPH) 2 gene unlike TPH-1 exhibits no association with stress-induced depression. Journal of Affective Disorders 2008, 107:1-3.
67. Grabe H.J., Schwahn C., Appel K., Mahler J., Schulz A., Spitzer C., Fenske K., Barnow S., Lucht M., Freyberger H.J., John U., Teumer A., Wallaschofski H., Nauck M., Volzke H. Childhood maltreatment, the corticotropin-releasing hormone receptor gene and adult depression in the general population. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2010, 153B:1483-1493.
68. Grabe H.J., Schwahn C., Mahler J., Appel K., Schulz A., Spitzer C., Fenske K., Barnow S., Freyberger H.J., Teumer A., Petersmann A., Biffar R., Rosskopf D., John U., Volzke H. Genetic epistasis between the brain-derived neurotrophic factor Val66Met polymorphism and the 5-HTT promoter polymorphism moderates the susceptibility to depressive disorders after childhood abuse. Progress in Neuro-psychopharmacology & Biological Psychiatry 2012, 36:264-270.
69. Gratacos M., Gonzalez J.R., Mercader J.M., de Cid R., Urretavizcaya M., Estivill X. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biological Psychiatry 2007, 61:911-922.
70. Haastrup E., Bukh J.D., Bock C., Vinberg M., Thorner L.W., Hansen T., Werge T., Kessing L.V., Ullum H. Promoter variants in IL18 are associated with onset of depression in patients previously exposed to stressful-life events. Journal of Affective Disorders 2012, 136:134-138.
71. Haeffel G.J., Getchell M., Koposov R.A., Yrigollen C.M., Deyoung C.G., Klinteberg B.A., Oreland L., Ruchkin V.V., Grigorenko E.L. Association between polymorphisms in the dopamine transporter gene and depression: evidence for a gene-environment interaction in a sample of juvenile detainees. Psychological Science 2008, 19:62-69.
72. Hajek T., Kopecek M., Hoschl C. Reduced hippocampal volumes in healthy carriers of brain-derived neurotrophic factor Val66Met polymorphism: meta-analysis. World Journal of Biological Psychiatry 2012, 13:178-187.
73. Hansel D.E., Eipper B.A., Ronnett G.V. Neuropeptide Y functions as a neuroproliferative factor. Nature 2001, 410:940-944.
74. Harrison P.J., Burnet P.W. The 5-HT2A (serotonin2A) receptor gene in the aetiology, pathophysiology and pharmacotherapy of schizophrenia. Journal of Psychopharmacology 1997, 11:18-20.
75. Hayden E.P., Klein D.N., Dougherty L.R., Olino T.M., Laptook R.S., Dyson M.W., Bufferd S.J., Durbin C.E., Sheikh H.I., Singh S.M. The dopamine D2 receptor gene and depressive and anxious symptoms in childhood: associations and evidence for gene-environment correlation and gene-environment interaction. Psychiatric Genetics 2010, 20:304-310.
76. Hayley S., Anisman H. Multiple mechanisms of cytokine action in neurodegenerative and psychiatric states: neurochemical and molecular substrates. Current Pharmaceutical Design 2005, 11:947-962.
77. Heilig M., Thorsell A. Brain neuropeptide Y (NPY) in stress and alcohol dependence. Reviews in the Neurosciences 2002, 13:85-94.
78. Heim C., Bradley B., Mletzko T.C., Deveau T.C., Musselman D.L., Nemeroff C.B., Ressler K.J., Binder E.B. Effect of childhood trauma on adult depression and neuroendocrine function: sex-specific moderation by CRH receptor 1 gene. Frontiers in Behavioral Neuroscience 2009, 3:41.
79. Hirschfeld R.M. The epidemiology of depression and the evolution of treatment. Journal of Clinical Psychiatry 2012, 73(Suppl 1):5-9.
80. Hosang G.M., Uher R., Keers R., Cohen-Woods S., Craig I., Korszun A., Perry J., Tozzi F., Muglia P., McGuffin P., Farmer A.E. Stressful life events and the brain-derived neurotrophic factor gene in bipolar disorder. Journal of Affective Disorders 2010, 125:345-349.
81. Huang Y.Y., Cate S.P., Battistuzzi C., Oquendo M.A., Brent D., Mann J.J. An association between a functional polymorphism in the monoamine oxidase a gene promoter, impulsive traits and early abuse experiences. Neuropsychopharmacology 2004, 29:1498-1505.
82. Huber K.M., Gallagher S.M., Warren S.T., Bear M.F. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:7746-7750.
83. Hung C.F., Lung F.W., Hung T.H., Chong M.Y., Wu C.K., Wen J.K., Lin P.Y. Monoamine oxidase A gene polymorphism and suicide: an association study and meta-analysis. Journal of Affective Disorders 2012, 136:643-649.
84. Ising M., Holsboer F. Genetics of stress response and stress-related disorders. Dialogues in Clinical Neuroscience 2006, 8:433-444.
85. Jin C., Xu W., Yuan J., Wang G., Cheng Z. Meta-analysis of association between the -1438A/G (rs6311) polymorphism of the serotonin 2A receptor gene and major depressive disorder. Neurological Research 2013, 35:7-14.
86. Johnson L.A., Phillips J.A., Mauer C., Edwards M., Balldin V.H., Hall J.R., Barber R., Conger T.L., Ho E.J., O'Bryant S.E. The impact of GPX1 on the association of groundwater selenium and depression: a project FRONTIER study. BMC Psychiatry 2013, 13:7.
87. Jokela M., Lehtimaki T., Keltikangas-Jarvinen L. The influence of urban/rural residency on depressive symptoms is moderated by the serotonin receptor 2A gene. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2007, 144:918-922.
88. Jokela M., Raikkonen K., Lehtimaki T., Rontu R., Keltikangas-Jarvinen L. Tryptophan hydroxylase 1 gene (TPH1) moderates the influence of social support on depressive symptoms in adults. Journal of Affective Disorders 2007, 100:191-197.
89. Juhasz G., Chase D., Pegg E., Downey D., Toth Z.G., Stones K., Platt H., Mekli K., Payton A., Elliott R., Anderson I.M., Deakin J.F. CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms. Neuropsychopharmacology 2009, 34:2019-2027.
90. Juhasz G., Dunham J.S., McKie S., Thomas E., Downey D., Chase D., Lloyd-Williams K., Toth Z.G., Platt H., Mekli K., Payton A., Elliott R., Williams S.R., Anderson I.M., Deakin J.F. The CREB1-BDNF-NTRK2 pathway in depression: multiple gene-cognition-environment interactions. Biological Psychiatry 2011, 69:762-771.
91. Karg K., Burmeister M., Shedden K., Sen S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Archives of General Psychiatry 2011, 68:444-454.
92. Kaufman J., Yang B.Z., Douglas-Palumberi H., Grasso D., Lipschitz D., Houshyar S., Krystal J.H., Gelernter J. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry 2006, 59:673-680.
93. Ke L., Qi Z.Y., Ping Y., Ren C.Y. Effect of SNP at position 40237 in exon 7 of the TPH2 gene on susceptibility to suicide. Brain Research 2006, 1122:24-26.
94. Kecmanovic D. Conceptual discord in psychiatry: origin, implications and failed attempts to resolve it. Psychiatria Danubina 2011, 23:210-222.
95. Kendler K.S. Twin studies of psychiatric illness: an update. Archives of General Psychiatry 2001, 58:1005-1014.
96. Kendler K.S., Neale M.C., Kessler R.C., Heath A.C., Eaves L.J. Familial influences on the clinical characteristics of major depression: a twin study. Acta Psychiatrica Scandinavica 1992, 86:371-378.
97. Kessler R.C., Chiu W.T., Demler O., Merikangas K.R., Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 2005, 62:617-627.
98. Kim J.M., Stewart R., Kim S.W., Yang S.J., Shin I.S., Kim Y.H., Yoon J.S. Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders. Biological Psychiatry 2007, 62:423-428.
99. Kia-Keating B.M., Glatt S.J., Tsuang M.T. Meta-analyses suggest association between COMT, but not HTR1B, alleles, and suicidal behavior. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2007, 144B:1048-1053.
100. Kishi T., Yoshimura R., Fukuo Y., Kitajima T., Okochi T., Matsunaga S., Inada T., Kunugi H., Kato T., Yoshikawa T., Ujike H., Umene-Nakano W., Nakamura J., Ozaki N., Serretti A., Correll C.U., Iwata N. The CLOCK gene and mood disorders: a case-control study and meta-analysis. Chronobiology International 2011, 28:825-833.
101. Kiyohara C., Yoshimasu K. Association between major depressive disorder and a functional polymorphism of the 5-hydroxytryptamine (serotonin) transporter gene: a meta-analysis. Psychiatric Genetics 2010, 20:49-58.
102. Laucht M., Treutlein J., Blomeyer D., Buchmann A.F., Schmid B., Becker K., Zimmermann U.S., Schmidt M.H., Esser G., Rietschel M., Banaschewski T. Interaction between the 5-HTTLPR serotonin transporter polymorphism and environmental adversity for mood and anxiety psychopathology: evidence from a high-risk community sample of young adults. International Journal of Neuropsychopharmacology/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2009, 12:737-747.
103. Lavebratt C., Aberg E., Sjoholm L.K., Forsell Y. Variations in FKBP5 and BDNF genes are suggestively associated with depression in a Swedish population-based cohort. Journal of Affective Disorders 2010, 125:249-255.
104. Leonard B., Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neuroscience and Biobehavioral Reviews 2012, 36:764-785.
105. Li D., He L. Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behavior. Molecular Psychiatry 2007, 12:47-54.
106. Lin P.I., Vance J.M., Pericak-Vance M.A., Martin E.R. No gene is an island: the flip-flop phenomenon. American Journal of Human Genetics 2007, 80:531-538.
107. Lin P.Y., Tsai G. Association between serotonin transporter gene promoter polymorphism and suicide: results of a meta-analysis. Biological Psychiatry 2004, 55:1023-1030.
108. Lopez-Leon S., Janssens A.C., Gonzalez-Zuloeta Ladd A.M., Del-Favero J., Claes S.J., Oostra B.A., van Duijn C.M. Meta-analyses of genetic studies on major depressive disorder. Molecular Psychiatry 2008, 13:772-785.
109. Lopez de Lara C., Brezo J., Rouleau G., Lesage A., Dumont M., Alda M., Benkelfat C., Turecki G. Effect of tryptophan hydroxylase-2 gene variants on suicide risk in major depression. Biological Psychiatry 2007, 62:72-80.
110. Lotrich F.E., Pollock B.G. Meta-analysis of serotonin transporter polymorphisms and affective disorders. Psychiatric Genetics 2004, 14:121-129.
111. Maletic V., Robinson M., Oakes T., Iyengar S., Ball S.G., Russell J. Neurobiology of depression: an integrated view of key findings. International Journal of Clinical Practice 2007, 61:2030-2040.
112. Malik A.I., Zai C.C., Abu Z., Nowrouzi B., Beitchman J.H. The role of oxytocin and oxytocin receptor gene variants in childhood-onset aggression. Genes Brain, and Behavior 2012, 11:545-551.
113. Mandelli L., Antypa N., Nearchou F.A., Vaiopoulos C., Stefanis C.N., Serretti A., Stefanis N.C. The role of serotonergic genes and environmental stress on the development of depressive symptoms and neuroticism. Journal of Affective Disorders 2012, 142:82-89.
114. Mandelli L., Nivoli A., Serretti A. Genetics of mood disorders. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes 2009, 125-133. Springer Science+Business Media B.V. M.S. Risner (Ed.).
115. Mandelli L., Serretti A., Marino E., Pirovano A., Calati R., Colombo C. Interaction between serotonin transporter gene, catechol-O-methyltransferase gene and stressful life events in mood disorders. International Journal of Neuropsychopharmacology 2007, 10:437-447.
116. Mann J.J., Currier D., Murphy L., Huang Y.Y., Galfalvy H., Brent D., Greenhill L., Oquendo M. No association between a TPH2 promoter polymorphism and mood disorders or monoamine turnover. Journal of Affective Disorders 2008, 106:117-121.
117. Mathers, C.D., Lopez, A.D., Murray, C.J.L., 2006. The burden of disease and mortality by condition: data, methods, and results for 2001. In: World Bank (Ed.), Global Burden of Disease and Risk Factors. Washington (DC).
118. McGuffin P., Katz R. Nature, nurture and affective disorder. The Biology of Affective Disorders 1986, Gaskell Press, London. R. Psychiatrist (Ed.).
119. McGuffin P., Rijsdijk F., Andrew M., Sham P., Katz R., Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Archives of General Psychiatry 2003, 60:497-502.
120. Mercader J.M., Ribases M., Gratacos M., Gonzalez J.R., Bayes M., de Cid R., Badia A., Fernandez-Aranda F., Estivill X. Altered brain-derived neurotrophic factor blood levels and gene variability are associated with anorexia and bulimia. Genes, Brain, and Behavior 2007, 6:706-716.
121. Mohler H. The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology 2012, 62:42-53.
122. Monteleone P., Bifulco M., Maina G., Tortorella A., Gazzerro P., Proto M.C., Di Filippo C., Monteleone F., Canestrelli B., Buonerba G., Bogetto F., Maj M. Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression. Pharmacological Research 2010, 61:400-404.
123. Morales-Medina J.C., Dumont Y., Quirion R. A possible role of neuropeptide Y in depression and stress. Brain Research 2010, 1314:194-205.
124. Munafo M.R., Durrant C., Lewis G., Flint J. Gene X environment interactions at the serotonin transporter locus. Biological Psychiatry 2009, 65:211-219.
125. Munafo M.R., Flint J. Replication and heterogeneity in gene x environment interaction studies. International Journal of Neuropsychopharmacology/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2009, 12:727-729.
126. Murphy T.M., Ryan M., Foster T., Kelly C., McClelland R., O'Grady J., Corcoran E., Brady J., Reilly M., Jeffers A., Brown K., Maher A., Bannan N., Casement A., Lynch D., Bolger S., Tewari P., Buckley A., Quinlivan L., Daly L., Kelleher C., Malone K.M. Risk and protective genetic variants in suicidal behaviour: association with SLC1A2, SLC1A3, 5-HTR1B & NTRK2 polymorphisms. Behavioral and Brain Functions 2011, 7:22.
127. National Center for Injury Prevention and Control (NCIPC), 2005.
128. Nederhof E., Bouma E.M., Oldehinkel A.J., Ormel J. Interaction between childhood adversity, brain-derived neurotrophic factor val/met and serotonin transporter promoter polymorphism on depression: the TRAILS study. Biological Psychiatry 2012, 68:209-212.
129. Nikulina V., Widom C.S., Brzustowicz L.M. Child abuse and neglect, MAOA, and mental health outcomes: a prospective examination. Biological Psychiatry 2012, 71:350-357.
130. Nyman E.S., Sulkava S., Soronen P., Miettunen J., Loukola A., Leppa V., Joukamaa M., Maki P., Jarvelin M.R., Freimer N., Peltonen L., Veijola J., Paunio T. Interaction of early environment, gender and genes of monoamine neurotransmission in the aetiology of depression in a large population-based Finnish birth cohort. BMJ Open 2011, 1:e000087.
131. Omrani M.D., Bushehri B., Bagheri M., Salari-Lak S., Alipour A., Anoshae M.R., Massomi R. Role of IL-10 -1082, IFN-gamma +874, and TNF-alpha -308 genes polymorphisms in suicidal behavior. Archives of Suicide Research 2009, 13:330-339.
132. Owen R.T. Glutamatergic approaches in major depressive disorder: focus on ketamine, memantine and riluzole. Drugs of Today (Barcelona, Spain) 2012, 48:469-478.
133. Paykel E.S. Life stress, depression and attempted suicide. Journal of Human Stress 1976, 2:3-12.
134. Pedersen N.L., Fiske A. Genetic influences on suicide and nonfatal suicidal behavior: twin study findings. European Psychiatry 2010, 25:264-267.
135. Pei Y., Smith A.K., Wang Y., Pan Y., Yang J., Chen Q., Pan W., Bao F., Zhao L., Tie C., Wang Y., Wang J., Zhen W., Zhou J., Ma X. The brain-derived neurotrophic-factor (BDNF) val66met polymorphism is associated with geriatric depression: a meta-analysis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2012, 159B:560-566.
136. Pendeville H., Carpino N., Marine J.C., Takahashi Y., Muller M., Martial J.A., Cleveland J.L. The ornithine decarboxylase gene is essential for cell survival during early murine development. Molecular and Cellular Biology 2001, 21:6549-6558.
137. Perea C.S., Paternina A.C., Gomez Y., Lattig M.C. Negative affectivity moderated by BDNF and stress response. Journal of Affective Disorders 2012, 136:767-774.
138. Perroud N., Aitchison K.J., Uher R., Smith R., Huezo-Diaz P., Marusic A., Maier W., Mors O., Placentino A., Henigsberg N., Rietschel M., Hauser J., Souery D., Kapelski P., Bonvicini C., Zobel A., Jorgensen L., Petrovic A., Kalember P., Schulze T.G., Gupta B., Gray J., Lewis C.M., Farmer A.E., McGuffin P., Craig I. Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project. Neuropsychopharmacology 2009, 34:2517-2528.
139. Perroud N., Courtet P., Vincze I., Jaussent I., Jollant F., Bellivier F., Leboyer M., Baud P., Buresi C., Malafosse A. Interaction between BDNF Val66Met and childhood trauma on adult's violent suicide attempt. Genes, Brain, and Behavior 2008, 7:314-322.
140. Perroud N., Jaussent I., Guillaume S., Bellivier F., Baud P., Jollant F., Leboyer M., Lewis C.M., Malafosse A., Courtet P. COMT but not serotonin-related genes modulates the influence of childhood abuse on anger traits. Genes, Brain, and Behavior 2010, 9:193-202.
141. Peyrot W.J., Middeldorp C.M., Jansen R., Smit J.H., de Geus E.J., Hottenga J.J., Willemsen G., Vink J.M., Virding S., Barragan I., Ingelman-Sundberg M., Sim S.C., Boomsma D.I., Penninx B.W. Strong effects of environmental factors on prevalence and course of major depressive disorder are not moderated by 5-HTTLPR polymorphisms in a large Dutch sample. Journal of Affective Disorders 2012.
142. Plyte S.E., Hughes K., Nikolakaki E., Pulverer B.J., Woodgett J.R. Glycogen synthase kinase-3: functions in oncogenesis and development. Biochimica et Biophysica Acta 1992, 1114:147-162.
143. Polanczyk G., Caspi A., Williams B., Price T.S., Danese A., Sugden K., Uher R., Poulton R., Moffitt T.E. Protective effect of CRHR1 gene variants on the development of adult depression following childhood maltreatment: replication and extension. Archives of General Psychiatry 2009, 66:978-985.
144. Quinn C.R., Dobson-Stone C., Outhred T., Harris A., Kemp A.H. The contribution of BDNF and 5-HTT polymorphisms and early life stress to the heterogeneity of major depressive disorder: a preliminary study. The Australian and New Zealand journal of psychiatry 2012, 46:55-63.
145. Ressler K.J., Bradley B., Mercer K.B., Deveau T.C., Smith A.K., Gillespie C.F., Nemeroff C.B., Cubells J.F., Binder E.B. Polymorphisms in CRHR1 and the serotonin transporter loci: gene×gene×environment interactions on depressive symptoms. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2010, 153B:812-824.
146. Risch N., Herrell R., Lehner T., Liang K.-Y., Eaves L., Hoh J., Griem A., Merikangas K.R. Interaction between the serotonin transporter gene (5-HTTLPR) stressful life events, and risk of depression: a meta-analysis. JAMA - Journal of the American Medical Association 2009, 301:2462-2471.
147. Risch N.J. Mapping genes for psychiatric disorders. Genetic Approaches to Mental Disorders 1994, American Psychiatric Press, Washington. E.S.G.C.R. Cloninger (Ed.).
148. Roy A., Gorodetsky E., Yuan Q., Goldman D., Enoch M.A. Interaction of FKBP5, a stress-related gene, with childhood trauma increases the risk for attempting suicide. Neuropsychopharmacology 2010, 35:1674-1683.
149. Roy A., Hodgkinson C.A., Deluca V., Goldman D., Enoch M.A. Two HPA axis genes, CRHBP and FKBP5, interact with childhood trauma to increase the risk for suicidal behavior. Journal of Psychiatric Research 2012, 46:72-79.
150. Roy A., Hu X.Z., Janal M.N., Goldman D. Interaction between childhood trauma and serotonin transporter gene variation in suicide. Neuropsychopharmacology 2007, 32:2046-2052.
151. Roy A., Sarchiopone M., Carli V. Gene-environment interaction and suicidal behavior. Journal of Psychiatric Practice 2009, 15:282-288.
152. Rujescu D., Thalmeier A., Moller H.J., Bronisch T., Giegling I. Molecular genetic findings in suicidal behavior: what is beyond the serotonergic system?. Archives of Suicide Research 2007, 11:17-40.
153. Ryan J., Ancelin M.L. Polymorphisms of estrogen receptors and risk of depression: therapeutic implications. Drugs 2012, 72:1725-1738.
154. Sanders A.R., Duan J., Gejman P.V. Complexities in psychiatric genetics. International Review of Psychiatry (Abingdon, England) 2004, 16:284-293.
155. Sarchiapone M., Carli V., Roy A., Iacoviello L., Cuomo C., Latella M.C., di Giannantonio M., Janiri L., de Gaetano M., Janal M.N. Association of polymorphism (Val66Met) of brain-derived neurotrophic factor with suicide attempts in depressed patients. Neuropsychobiology 2008, 57:139-145.
156. Saveanu R.V., Nemeroff C.B. Etiology of depression: genetic and environmental factors. Psychiatric Clinics of North America 2012, 35:51-71.
157. Seltzer M.M., Barker E.T., Greenberg J.S., Hong J., Coe C., Almeida D. Differential sensitivity to life stress in FMR1 premutation carrier mothers of children with fragile X syndrome. Health Psychology 2012, 31:612-622.
158. Serretti A., Calati R., Mandelli L., De Ronchi D. Serotonin transporter gene variants and behavior: a comprehensive review. Current Drug Targets 2006, 7:1659-1669.
159. Shinozaki G., Romanowicz M., Passov V., Rundell J., Mrazek D., Kung S. State dependent gene-environment interaction: serotonin transporter gene-child abuse interaction associated with suicide attempt history among depressed psychiatric inpatients. Journal of Affective Disorders 2013, 147:1-3.
160. Sokolowski M., Ben-Efraim Y.J., Wasserman J., Wasserman D. Glutamatergic GRIN2B and polyaminergic ODC1 genes in suicide attempts: associations and gene-environment interactions with childhood/adolescent physical assault. Molecular Psychiatry 2013, (in press).
161. Sommer W.H., Lidstrom J., Sun H., Passer D., Eskay R., Parker S.C., Witt S.H., Zimmermann U.S., Nieratschker V., Rietschel M., Margulies E.H., Palkovits M., Laucht M., Heilig M. Human NPY promoter variation rs16147:T>C as a moderator of prefrontal NPY gene expression and negative affect. Human Mutation 2010, 31:E1594-E1608.
162. Sullivan P.F. Spurious genetic associations. Biological Psychiatry 2007, 61:1121-1126.
163. Sun N., Xu Y., Wang Y., Duan H., Wang S., Ren Y., Peng J., Du Q., Shen Y., Xu Q., Zhang K. The combined effect of norepinephrine transporter gene and negative life events in major depression of Chinese Han population. Journal of Neural Transmission 2008, 115:1681-1686.
164. Terracciano A., Lobina M., Piras M.G., Mulas A., Cannas A., Meirelles O., Sutin A.R., Zonderman A.B., Uda M., Crisponi L., Schlessinger D. Neuroticism, depressive symptoms, and serum BDNF. Psychosomatic Medicine 2011, 73:638-642.
165. Terracciano A., Martin B., Ansari D., Tanaka T., Ferrucci L., Maudsley S., Mattson M.P., Costa P.T. Plasma BDNF concentration, Val66Met genetic variant and depression-related personality traits. Genes, Brain, and Behavior 2010, 9:512-518.
166. Teyssier J.R., Ragot S., Chauvet-Gelinier J.C., Trojak B., Bonin B. Expression of oxidative stress-response genes is not activated in the prefrontal cortex of patients with depressive disorder. Psychiatry Research 2011, 186:244-247.
167. Thompson N.M., Gulley M.L., Rogeness G.A., Clayton R.J., Johnson C., Hazelton B., Cho C.G., Zellmer V.T. Neurobehavioral characteristics of CGG amplification status in fragile X females. American Journal of Medical Genetics 1994, 54:378-383.
168. Thompson R.J., Parker K.J., Hallmayer J.F., Waugh C.E., Gotlib I.H. Oxytocin receptor gene polymorphism (rs2254298) interacts with familial risk for psychopathology to predict symptoms of depression and anxiety in adolescent girls. Psychoneuroendocrinology 2011, 36:144-147.
169. Tobacco and Genetics Consortium Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nature Genetics 2010, 42:441-447.
170. Tovilla-Zarate C., Juarez-Rojop I., Ramon-Frias T., Villar-Soto M., Pool-Garcia S., Medellin B.C., Genis Mendoza A.D., Narvaez L.L., Humberto N. No association between COMT val158met polymorphism and suicidal behavior: meta-analysis and new data. BMC Psychiatry 2011, 11:151.
171. Tsai S.J., Hong C.J., Liou Y.J. Recent molecular genetic studies and methodological issues in suicide research. Progress in Neuro-psychopharmacology & Biological Psychiatry 2011, 35:809-817.
172. Tyzio R., Cossart R., Khalilov I., Minlebaev M., Hubner C.A., Represa A., Ben-Ari Y., Khazipov R. Maternal oxytocin triggers a transient inhibitory switch in GABA signaling in the fetal brain during delivery. Science (New York, NY) 2006, 314:1788-1792.
173. Verhagen M., van der Meij A., van Deurzen P.A., Janzing J.G., Arias-Vasquez A., Buitelaar J.K., Franke B. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Molecular Psychiatry 2010, 15:260-271.
174. Wang L., Ashley-Koch A., Steffens D.C., Krishnan K.R., Taylor W.D. Impact of BDNF Val66Met and 5-HTTLPR polymorphism variants on neural substrates related to sadness and executive function. Genes, Brain, and Behavior 2012, 11:352-359.
175. Wasserman D., Geijer T., Sokolowski M., Rozanov V., Wasserman J. The serotonin 1A receptor C(-1019)G polymorphism in relation to suicide attempt. Behavioral and Brain Functions 2006, 2:14.
176. Wasserman D., Sokolowski M., Rozanov V., Wasserman J. The CRHR1 gene: a marker for suicidality in depressed males exposed to low stress. Genes, Brain, and Behavior 2008, 7:14-19.
177. Watanabe Y., Nunokawa A., Someya T. Association of the BDNF C270T polymorphism with schizophrenia: updated meta-analysis. Psychiatry and Clinical Neurosciences 2013, 67:123-125.
178. Wichers M., Kenis G., Jacobs N., Mengelers R., Derom C., Vlietinck R., van Os J. The BDNF Val(66)Met×5-HTTLPR×child adversity interaction and depressive symptoms: an attempt at replication. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2008, 147B:120-123.
179. Willour V.L., Chen H., Toolan J., Belmonte P., Cutler D.J., Goes F.S., Zandi P.P., Lee R.S., MacKinnon D.F., Mondimore F.M., Schweizer B., DePaulo J.R., Gershon E.S., McMahon F.J., Potash J.B. Family-based association of FKBP5 in bipolar disorder. Molecular Psychiatry 2009, 14:261-268.
180. World Health Organization Impact of disorders 2001, http://www.who.int/whr/2001/chapter2/en/index3.html.
181. Wu Y., Wang X., Shen X., Tan Z., Yuan Y. The I/D polymorphism of angiotensin-converting enzyme gene in major depressive disorder and therapeutic outcome: a case-control study and meta-analysis. Journal of Affective Disorders 2012, 136:971-978.
182. Xu Y., Li F., Huang X., Sun N., Zhang F., Liu P., Yang H., Luo J., Sun Y., Zhang K. The norepinephrine transporter gene modulates the relationship between urban/rural residency and major depressive disorder in a Chinese population. Psychiatry Research 2009, 168:213-217.
183. Yang C., Xu Y., Sun N., Ren Y., Liu Z., Cao X., Zhang K. The combined effects of the BDNF and GSK3B genes modulate the relationship between negative life events and major depressive disorder. Brain Research 2010, 1355:1-6.
184. Yoon, H.K., Kim, Y.K., 2009. TPH2 -703G/T SNP may have important effect on susceptibility to suicidal behavior in major depression. Progress in neuro-psychopharmacology & biological psychiatry 33, 403-409.
185. Zai C.C., Manchia M., De Luca V., Tiwari A.K., Chowdhury N.I., Zai G.C., Tong R.P., Yilmaz Z., Shaikh S.A., Strauss J., Kennedy J.L. The brain-derived neurotrophic factor gene in suicidal behaviour: a meta-analysis. International Journal of Neuropsychopharmacology/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2012, 15:1037-1042.
186. Zalsman G., Huang Y.Y., Oquendo M.A., Burke A.K., Hu X.Z., Brent D.A., Ellis S.P., Goldman D., Mann J.J. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. American Journal of Psychiatry 2006, 163:1588-1593.
187. Zhang H.L., Wu J., Zhu J. The role of apolipoprotein E in Guillain-Barre syndrome and experimental autoimmune neuritis. Journal of Biomedicine & Biotechnology 2010, 2010:357412.
188. Zhang H.Y., Ishigaki T., Tani K., Chen K., Shih J.C., Miyasato K., Ohara K., Ohara K. Serotonin2A receptor gene polymorphism in mood disorders. Biological Psychiatry 1997, 41:768-773.
189. Zhang Y., Zhang C., Yuan G., Yao J., Cheng Z., Liu C., Liu Q., Wan G., Shi G., Cheng Y., Ling Y., Li K. Effect of tryptophan hydroxylase-2 rs7305115 SNP on suicide attempts risk in major depression. Behavioral and Brain Functions 2010, 6:49.
190. Zill P., Buttner A., Eisenmenger W., Moller H.J., Bondy B., Ackenheil M. Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims. Biological Psychiatry 2004, 56:581-586.
191. Zimmermann P., Bruckl T., Nocon A., Pfister H., Binder E.B., Uhr M., Lieb R., Moffitt T.E., Caspi A., Holsboer F., Ising M. Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study. American Journal of Psychiatry 2011, 168:1107-1116.
192. Zupanc T., Pregelj P., Tomori M., Komel R., Paska A.V. TPH2 polymorphisms and alcohol-related suicide. Neuroscience Letters 2011, 490:78-81.